The North-Western Italian experience with anti IL-5 therapy amd comparison with regulatory trials

The severe forms of asthma represent a major burden, because of severity of symptoms, costs and impact on everyday life. Recently, Mepolizumab (MEP) was approved and marketed for the treatment of hypereosinoph...

https://ift.tt/2AVDcdh